May 24, 2024

Antiseptic nasal decolonization noses ahead

Over 20 years ago, an article from Johns Hopkins published in The New England Journal of Medicine showed that Staphylococcus aureus decolonization of the nares can decrease risk of surgical site infections (SSI). Since then, nasal decolonization—the application of a topical antimicrobial or antiseptic agent to the nares—has been adopted as a well-regarded infection prevention practice. And with upwards of 70% to 95% of all SSIs originating in the microbiome of the patient’s own skin or nares, it is no wonder that medical professionals are embracing this easy, low-risk approach to reduce the risk of healthcare-associated infections (HAI).

Welcome to OR Manager, your source of information and insight into the clinical and business management of the surgical suite. This article is only available to OR Manager subscribers. To read this article, and gain access to all OR Manager resources, please log in below:

Join the OR Manager Community! OR Manager is the trusted source for perioperative leaders, providing critical information, analysis, and best practices for management of the surgical suite. Join as a Premium Subscriber to access all articles online including archives, the digital issue of OR Manager each month, eligibility for CE contact hours, registration discounts on conferences and more. We also offer a complimentary Plus subscription to those who qualify and a complimentary Community subscription.

Explore Subscription Options

Please contact our Customer Service Team if you are unable to log in at [email protected] or 1-888-707-5814.

Live chat by BoldChat